← All trials
NCT06924827
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 2, 2026
- Primary completion
- Feb 2, 2028
- Completion date
- Dec 31, 2028
- First posted
- Apr 11, 2025
- Last posted
- Sep 24, 2025
- Enrollment
- 25
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of TorontoLead sponsor
- Jazz PharmaceuticalsCollaborator
- University of TorontoOfficial
- University of British ColumbiaCollaborator
- University of CalgaryCollaborator
- University of TorontoSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.